Coronary stent / drug eluting BioFreedom™ Biosensors BV

Coronary stent / drug eluting BioFreedom™ Biosensors BV
BioFreedom™


Drug Eluting Stents (DES) are proven to reduce the risk of restenosis and improve outcomes for patients with more complex coronary disease. However, in certain patients where there is a requirement to avoid prolonged Dual Anti-Platelet Therapy (DAPT), Bare Metal Stents (BMS) may be preferred. BioFreedom™, as a Drug-Coated Stent (DCS), combines the advantages of both DES and BMS. It delivers an effective anti-restenotic therapy with Biolimus A9™, and may shorten the required DAPT1 regime.
  • Characteristics:drug eluting
  • Cardiovascular system :coronary
******
rue de Lausanne 29,
Morges
Switzerland
× × × × × × ×


Endorsed Companies